Zymeworks Inc. ZYME 深 滬
等待開盤 05-19 09:30:00 美东时间
24.43
+0.500
+2.09%
華盛通- 最 高24.70
- 今 開23.93
- 成交量 75.02万股
- 最 低 23.88
- 昨 收 23.93
- 總市值 17.97亿
- 52周最高 29.75
- 市盈率 靜 --
- 換手率 1.02%
- 52周最低 11.02
- 委 比 -42.45%
- 總股本 7357.39万
- 歷史最高 59.03
- 量 比 1.00
- 振 幅 3.43%
- 歷史最低 4.11
- 每 手 1
- 風險率 5.49%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Zymeworks Announces $125M Buyback Plan
Zymeworks Inc. (NASDAQ:ZYME), a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse pipeline of novel, multifunctional biotherapeutics, today announced that its Board of
05-15 04:25
Zymeworks authorizes fresh $125M share buyback
Zymeworks (ZYME) on Thursday said its board approved a new 2026 share repurchase program authorizing the company to buy back up to $125M of its common stock. The biotechnology company also terminated ...
05-15 04:18
Zymeworks Announces Participation in Upcoming Investor Conferences
Zymeworks Inc. announced that its management will participate in three upcoming investor conferences: the 2026 Stifel Virtual Targeted Oncology Forum on May 20, the TD Cowen 7th Annual Oncology Innovation Summit on May 27, and the 2026 Jefferies Global Healthcare Conference on June 3. The company focuses on developing innovative biotherapeutics for challenging diseases like cancer, inflammation, and autoimmune conditions, leveraging its proprieta...
05-13 10:00
美股大行评级 | 爱彼迎、Affirm、CoreWeave、Datadog、微芯科技等获多家大行上调目标价；HubSpot惨遭14家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Artiva Biotherapeutics"买入"评级，目标价从15美元升至35美元；韦德布什：维持Cullinan Therapeutics"跑赢大市"评级，目标价从36美元升至37美元
05-11 15:43
Wells Fargo Maintains Overweight on Zymeworks, Raises Price Target to $34
Wells Fargo analyst Eva Fortea Verdejo maintains Zymeworks (NASDAQ:ZYME) with a Overweight and raises the price target from $33 to $34.
05-08 21:39
Zymeworks Q1 EPS $(0.59) Down From $(0.30) YoY, Sales $2.408M Down From $27.110M YoY
Zymeworks (NASDAQ:ZYME) reported quarterly losses of $(0.59) per share. This is a 96.67 percent decrease over losses of $(0.30) per share from the same period last year. The company reported $2.408 million in sales this
05-08 04:28
Here are the major earnings after the close Thursday
Major earnings expected after the bell on Thursday include: Gilead Sciences (GILD) Block (XYZ) Airbnb (ABNB) Coinbase Global (COIN) The Trade Desk (TTD) Other Earnings slated for release after Thursda...
05-07 22:00
Royalty Pharma Reports Q1 2026 Results: Full Earnings Call Transcript
Royalty Pharma (NASDAQ:RPRX) held its first-quarter earnings conference call on...
05-06 21:56
美股大行评级 | 潜在涨幅15%！15家大行集体上调德州仪器目标价；CSX运输、拉姆研究、金沙集团、马斯可木业、Vertiv Holdings等获多家大行上调目标价
今日重点评级关注：花旗：维持Pegasystems"买入"评级，目标价从70美元升至71美元；巴克莱：维持曼哈顿联合软件"超配"评级，目标价从236美元升至239美元
04-24 12:10
